EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of high-grade non-Hodgkin's lymphomas with short intensive chemotherapy (MACOP-B)



Treatment of high-grade non-Hodgkin's lymphomas with short intensive chemotherapy (MACOP-B)



Bulletin du Cancer (Paris) 80(9): 808-815



We present our results of a MACOP-B regimen in a series of 46 patients with high-grade NHL. The complete remission rate was 74% for patients with advanced stage disease. The excellent tolerance allowed this regimen to be given on an outpatient basis in the majority of cases. The median follow-up for the living patients is 28 months.

(PDF emailed within 1 workday: $29.90)

Accession: 009672825

Download citation: RISBibTeXText



Related references

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas. Leukemia 5 Suppl 1: 74-78, 1991

MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas. Leukemia & Lymphoma 16(5-6): 457-463, 1995

MACOP-B treatment for intermediate and high-grade non-Hodgkin's lymphomas at diagnosis and in relapse. Haematologica 75(2): 149-154, 1990

MACOP-B chemotherapy for the treatment of high grade and intermediate grade non Hodgkin's lymphoma. Blut 60(1): 23-27, 1990

MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection. Acta Haematologica 89(1): 10-12, 1993

Treatment results with an aggressive chemotherapeutic regimen (MACOP-B) for intermediate- and some high-grade non-Hodgkin's lymphomas. Journal of Clinical Oncology 8(1): 94-102, 1990

Treatment of low grade and intermediate grade non-Hodgkin's lymphomas with intensive combination chemotherapy. Haematologica 84(E-Letters): E03-E03, 2000

Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas. Tumori 73(2): 121-126, 1987

Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen. Blood 82(12): 3564-3573, 1993

Combination chemotherapy of intermediate-grade and high-grade non-Hodgkin's lymphoma with MACOP-B: a Southwest Oncology Group study. Journal of Clinical Oncology 9(5): 748-753, 1991

Treatment of high malignancy lymphoma with intensive short-term chemotherapy using the MACOP-B regimen. Bulletin du Cancer 80(9): 808-815, 1993

Modified MACOP-B chemotherapy for intermediate and high grade non Hodgkins lymphomas. Journal of the Association of Physicians of India 42(10): 781-784, 1994

Combination chemotherapy of intermediate grade and high grade non hodgkin's lymphoma with macop b a southwest oncology group study san antonio texas usa. Journal of Clinical Oncology 9(5): 748-753, 1991

Intensive treatment of AIDS-related non-Hodgkin's lymphomas with MACOP-B protocol. European Journal of Haematology 54(2): 73-77, 1995

Intensive treatment of AIDS-related non-Hodgkin's lymphomas with the MACOP-B protocol. European Journal of Haematology 54(2): 73-77, 1995